Chronic fatigue syndrome is associated with diminished intracellular perforin.
about
Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case seriesA Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)?Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristicsImpaired immune function in Gulf War Illness.Determination of quantitative and site-specific DNA methylation of perforin by pyrosequencingBiomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.Chronic Fatigue Syndrome: The Current Status and Future Potentials of Emerging Biomarkers.DNA methylation modifications associated with chronic fatigue syndrome.A formal analysis of cytokine networks in chronic fatigue syndrome.Acute psychosocial stress-mediated changes in the expression and methylation of perforin in chronic fatigue syndrome.Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disordersNatural killer cells in patients with severe chronic fatigue syndrome.Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME)Serum Immune Proteins in Moderate and Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients.Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis.Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome.ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.Validating a measure of myalgic encephalomyelitis/chronic fatigue syndrome symptomatologyEvidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood.Novel identification and characterisation of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signalling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients.The association of IFI27 expression and fatigue intensification during localized radiation therapy: implication of a para-inflammatory bystander response.Dysregulation of Protein Kinase Gene Expression in NK Cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients.Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome.Examining the impact of obesity on individuals with chronic fatigue syndrome.Oxidative and Nitrosative Stress and Immune-Inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).Intermittent and graded exercise effects on NK cell degranulation markers LAMP-1/LAMP-2 and CD8+CD38+ in chronic fatigue syndrome/myalgic encephalomyelitis.Immune and hemorheological changes in chronic fatigue syndromeUnperturbed Cytotoxic Lymphocyte Phenotype and Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways.Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study.Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation.Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).Longitudinal associations of lymphocyte subsets with clinical outcomes in chronic fatigue syndromeAltered Cd8+ T lymphocyte Response Triggered by Arginase 1: Implication for Fatigue Intensification during Localized Radiation Therapy in Prostate Cancer PatientsLoss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
P2860
Q24647924-47BA894A-3ADC-432D-BF51-94745DEB0599Q26747503-1ADCF8E9-A86D-48E6-8B30-6505007CB0DAQ26998412-BA269C82-945B-4662-A5F5-026EE8931B19Q33415355-713D2E2A-4247-47B1-BD76-C69DE41D7797Q33467093-9BBC4534-A8B6-46AF-AAF8-E20E76BE7335Q33593176-48E22B67-8619-4DB4-8D7D-2201A7F8CAB9Q33737919-ACD6320D-E2A0-4A0A-9943-2C6186017944Q34027879-BBCF81E9-ACEA-4922-809C-EB636EB5DEDFQ34126219-BD7A3405-9EE5-4AD8-A2B2-34268149A655Q34463050-9BB7B6DB-DDFB-4AE2-91BC-BC35A954A083Q35059951-71A0736C-6A36-4061-8382-901258BC83FCQ35061216-49EDF357-B18B-4731-B719-7AF5FEEDD614Q35246024-94EBF2F2-0946-45B4-A079-3899566C8824Q35309120-7B13B5CE-5AD8-479F-8227-B5B2D46AA226Q35648873-F7ACFBE8-DB7F-41E9-B711-825009D9E4F5Q35954084-05DFD84F-CE0F-4B8B-92B0-4B6E0969BF4BQ36189738-4AC9261E-2BA3-4DDC-881F-AFAB03A0CECAQ36298951-FC4D9060-278E-4A2A-9F89-1B55D7C8DEC8Q36399124-52949FF6-7E26-41D3-9438-F981CA6043E3Q36516368-5EF59341-3852-4077-B6B5-07577946F800Q36766834-04D5E400-1781-46A9-A31B-319745A2573BQ36820322-E132CD21-3D55-4F98-9374-1DABB880CF15Q36913215-F236E1C2-1DA3-4DCC-AF27-F184DF09D40DQ36942613-329DCE28-D376-4359-8042-24BB3C864D4FQ36955692-38710913-315C-4F9F-B7F4-608472C21DBAQ37139246-C73E4D1E-CEA4-46BC-B867-356CBB494195Q37213332-D265CC60-0DD8-4CA5-97FC-66D93874EF6DQ37484088-592AA4CA-A3A6-40FF-87CB-D742AA7FA29EQ37507167-7F3D49C0-0029-4457-AC65-874450AD20C8Q37661367-9EDBA9DB-0907-4149-9F19-9B3FCD51C5E6Q37699630-796580B3-B088-438D-9263-11A9B0F8D551Q39311866-272C6635-9CEB-450C-AB2D-3BE6123063B9Q40128256-53A0EA1A-CD76-4090-A683-014F2F623305Q42735475-A06E8B0F-A6C5-43AC-9FC9-727DB4FFF5EDQ50689763-5118BC71-FB4D-42DB-B870-9A48C0588E77Q51733779-204DA027-5634-4989-8785-A1512BA1D2DCQ55387468-F0FDA7BB-BC68-4451-939B-F6BA29DE7160Q57565816-AF71921A-E9D2-46EC-AFEB-85F820C65910Q58582886-3CA0BE50-C1CF-4026-8E3F-85BA44F80391Q58782400-2EB8C014-F96A-490F-BCEA-D690ED8F1070
P2860
Chronic fatigue syndrome is associated with diminished intracellular perforin.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Chronic fatigue syndrome is associated with diminished intracellular perforin.
@ast
Chronic fatigue syndrome is associated with diminished intracellular perforin.
@en
Chronic fatigue syndrome is associated with diminished intracellular perforin.
@nl
type
label
Chronic fatigue syndrome is associated with diminished intracellular perforin.
@ast
Chronic fatigue syndrome is associated with diminished intracellular perforin.
@en
Chronic fatigue syndrome is associated with diminished intracellular perforin.
@nl
prefLabel
Chronic fatigue syndrome is associated with diminished intracellular perforin.
@ast
Chronic fatigue syndrome is associated with diminished intracellular perforin.
@en
Chronic fatigue syndrome is associated with diminished intracellular perforin.
@nl
P2093
P2860
P1476
Chronic fatigue syndrome is associated with diminished intracellular perforin.
@en
P2093
M A Fletcher
N G Klimas
P2860
P304
P356
10.1111/J.1365-2249.2005.02935.X
P577
2005-12-01T00:00:00Z